Form 4: Rezolute Director Philippe Fauchet Granted New Equity Awards

Rezolute, Inc. Director Philippe Fauchet was granted 9,000 restricted stock units and 5,000 stock options on June 10, 2025, as part of his compensation.

Summary

• Philippe Fauchet, a Director of Rezolute, Inc. (RZLT), acquired new equity awards.
• On June 10, 2025, he was granted 9,000 common shares in the form of restricted stock units (RSUs) at a price of $0 per share.
• These 9,000 RSUs are scheduled to vest 100% on July 1, 2026.
• He also acquired 5,000 Director Stock Options with an exercise price of $4.39 per share, granted at a price of $0.
• These 5,000 stock options also vest 100% on July 1, 2026, and have an expiration date of June 10, 2035.
• Following these transactions, Mr. Fauchet beneficially owns 34,500 common shares and 5,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The filing reports a routine grant of equity compensation to a director, which is a neutral event but can be seen as slightly positive as it aligns the director's interests with shareholders.

Positives

• The grant of equity awards to a director helps align their interests with those of the company's shareholders.
• Equity grants are a standard component of director compensation, indicating continued engagement and commitment to the company.

Future Outlook

The document indicates future vesting events for the granted restricted stock units and stock options on July 1, 2026, and the expiration of the stock options on June 10, 2035.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation. The granting of equity awards like restricted stock units and stock options is a common practice across various industries, particularly in the biotechnology and pharmaceutical sectors where long-term incentives are used to retain key talent and align management interests with company performance.

Related Party Transactions

• The grant of 9,000 restricted stock units and 5,000 stock options to Philippe Fauchet, a director, constitutes a related-party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The equity grants further align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• Vesting of 9,000 restricted stock units on July 1, 2026.
• Vesting of 5,000 stock options on July 1, 2026.
• Potential exercise of stock options by June 10, 2035.

Key Dates

Keywords

Rezolute Inc., RZLT, Philippe Fauchet, Form 4, SEC filing, insider transaction, director compensation, restricted stock units, stock options, equity grant, beneficial ownership